MedTrace Logo

Pharmacokinetics and Metabolism Study in Healthy Male Participants

NCT03247283 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2017-11-06

No results posted yet for this study

Summary

Phase 1 Phamacokinetic and metabolism study of BMS-986205 in healthy males

Conditions

Interventions

DRUG

BMS-986205

Carbon 14 tagged BMS-986205

Sponsors & Collaborators

Principal Investigators

  • Bristol- Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-19
Primary Completion
2017-10-15
Completion
2017-10-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03247283 on ClinicalTrials.gov